A Review on Bio-Polymers Derived from Animal Sources with Special Reference to their Potential Applications

Review bio-polymer animal sources applications

  • Biplajit Das School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India
  • Sujata Paul Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India
  • Hemanta Kumar Sharma Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India https://orcid.org/0000-0003-2632-4903

Abstract

Biopolymers are naturally found material and most of the materials are made in nature during the life cycles of plants, animals, fungi and bacteria. For any pharmaceutical formulation the two main ingredients are active pharmaceutical ingredient and excipients. As excipients in any kind of dosage form, the biopolymers play a vital function. Biopolymers are pharmacologically inert ingredients formulated along with the active ingredient to increase the volume; they help in the formulating dosage form and also simultaneously can improve the physicochemical parameters of the dosage form and so are widely used in the development of new drug delivery system. The biopolymers which are obtained from animal sources are usually non-toxic, biocompatible, stable and economic; and can control the release pattern of the drug. Natural polymers have more preponderant effects on fast dissolving tablets than synthetic polymers. Now-a-days, because of many problems regarding drug release and adverse effects of synthetic polymers, manufacturers are going towards using natural polymers. In this review article we mainly discussed about types of polymer, different alignment of natural polymer, advantages of natural polymers over synthetic polymers, drawbacks of natural polymers, mechanism of drug release of polymer, different methods of preparation of biopolymers, role of polymer in pharmaceutical industry and drug delivery systems.


Keywords: Natural polymers, Chitin, Collagen, Sources, Preparation.

Keywords: Natural polymers, Chitin, Collagen, Sources, Preparation

Downloads

Download data is not yet available.

Author Biographies

Biplajit Das, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India

Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India

Sujata Paul, Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India

Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India

Hemanta Kumar Sharma, Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India

Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India

References

1. Gopalrao M, Bharathi P, Akila RM, “A comprehensive review on biopolymers” SRCC, 2014; 4(2):61-68.
2. Kaushik K, Sharma RB, Agarwal S, “Natural Polymers and their Applications” Int J Pharm Sci Rev Res, 2016; 37(2):30-36.
3. Saripilli R, Teella P, Navya S, Swain RP et al., “Natural polymers: a recent review” WJPPS, 2017; 6(8):472-494.
4. Ananthakumar R, Chitra K, Satheshkumar S, “A review on applications of natural polymers in gastroretentive drug delivery system” Drug Invent, 2018; 10(3):285-218.
5. Kalia S, Averous L, “Biopolymers: Biomedical and Environmental Applications. 1st ed. Salem: Wiley-Scrivener; 2010. P. 559-574.
6. Jana S, Gandhi A, Sen KK, Basu SK, “Natural Polymers and their Application in Drug Delivery and Biomedical Field” JPST, 2011; 1(1):16-27.
7. Thomas B. Goudoulas, “Polymers and Biopolymers as Drug Delivery Systems in Nanomedicine” Recent Pat Nanotechnol, 2012; 2:52-61.
8. Jae YJ, Se-KK, “Chitosan as Potential Marine Nutraceutical” Adv Food Nutr Res, 2012; 65:122-132.
9. Casparus J, Reinhard V, “Products and applications of biopolymers” Intech, 2012; 6(2):1-201.
10. Singh AV, “Biopolymers in Drug Delivery: A Review” Pharmacologyonline, 2011; 1:666-674.
11. Sevda SE, Susan JM. “Potential applications of chitosan in veterinary medicine” Adv Drug Deliv Rev, 2004; 56(2):1467– 1480.
12. Basel Y, “Classification, characterization, and the production processes of biopolymers used in the textiles industry” J Text Inst, 2016; 10(3):1754-2340.
13. Jane GT, David AT, “Synthesis of biopolymers: proteins, polyesters, polysaccharides and polynucleotides” Curr Opin Solid State Mater Sci, 1996; 1:407-411.
14. Jency G, Jegan SR, Mahija SP, “Collagen and Its Therapeutical Applications in Regenerative Medicine” IJSRD, 2018; 6(1): 2321-2613.
15. Krushnakumar J, Gandhi S, Deshmane V, Kailash RB, “Polymers in pharmaceutical drug delivery system” IJPSR, 2012; 14(2):57-66.
16. Sreeraj G, Augustine A, Sabu T, “Effective Drug Delivery System of Biopolymers Based On Nanomaterials and Hydrogels - A Review” Drug Des, 2016; 5(2):2-7.
17. Dutta PK, Dutta J, Tripathi VS, “Chitin Chitosan: Chemistry Property and Application” JSIR, 2004; 63:20-31.
18. Yadav P, Yada H, Shah GV et al, “Biomedical Biopolymers, their Origin and Evolution in Biomedical Sciences: A Systematic Review” JCDR, 2015; 9(9):21-25.
19. Hamed N, Samiramis P, Esmaeel S, “A Review on Some Natural Biopolymers and Their Applications in Angiogenesis and Tissue Engineering” JAB, 2018; 5(3):81-91.
20. IslemY, Marguerite R, “Chitin and Chitosan Preparation from Marine Sources. Structure.Properties and Applications” Mar drugs, 2015; 13:1133-1174.
21. Hengameh H, Mehdi B, “Applications of biopolymers I: chitosan” Monatsh Chem, 2009; 140:1403–1420.
22. Lakshmana PS, Suriyaprakash TNK, “Role of Natural Polymers in Drug Delivery Systems as Challenging Ailments” Nov Appro Drug Des Dev, 2017; 3(1):1-3.
23. Daniel EAK, Michael RH, “Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials” Int J Adv Res, 2016; 4(3):411–427.
24. Shigehiro H, “Chitin and chitosan as novel biotechnological Materials” Polym Int, 1999; 48:732-734.
25. Deming TJ, Fournier MJ, Mason TL, Tirrell DA, “Structural modification of a periodic polypeptide through biosynthetic replacement of proline with azetidine-2-cerboxylic acid” Macromol, 1996; 29(4):1442-l 444.
26. Laura GRB, Mirna LSA, “Collagen: A review on its sources and potential cosmetic Applications” J Cosmet Dermatol, 2018; 17:20–26.
27. Babu RP, Connor KO, Ramakrishna S, “Current progress on bio-based polymers and their future trends” Prog Biomater, 2013; 2(8):1-16.
28. Chak V, Kumar D, Sharad V, “A Review on Collagen Based Drug Delivery Systems” IJPTP, 2013; 4(4):811-820.
29. Saripilli R, Teella P, Navya S et al., “Natural polymers: a recent review” WJPPS, 2017; 6(8):472-494.
30. Maytal F, Meital Z, “Drug delivery from gelatin-based systems” Expert Opin Drug Deliv, 2015; 12(9):1547-1563.
31. Kamrun N, Hossain K, Khan TA, “Alginate and Its Versatile Application in Drug Deliv” JPSR, 2017; 9(5): 606-617.
32. Joby J, Jozef TH, Sabu T, Sreeraj G, “Biopolymer based nanomaterials in drug delivery systems: A review” Mater Today Chem, 2018; 9:43-45.
33. Sharma KA, “Biopolymers in Drug Delivery” Biopolymers Res, 2017; 1(1):1-3.
34. Abdulsalam A, Nafaa A, Marwan A, “Xanthan gum; Its Biopharmaceutical Applications: An Overview” WJPPS, 2017; 7(1):1536-1548.
35. Chun YH, Jen MK, Shu JW, Hsing TT, “Isolation and characterization of fish scale collagen from tilapia (Oreochromis sp.) by a novel extrusion hydro-extraction process” Food Chem, 2016; 190:997-1006.
36. Maytal F, Meital Z, “Drug delivery from gelatin-based systems” Expert Opin Drug Deliv, 2015; 6(2):742-5247.
37. Patil GV, “Biopolymer Albumin for Diagnosis and In Drug Delivery” Drug Development Research, 2003; 58:219–247.
38. Faiza A, Wafa A, Mayson HA, “Biopolymers and Drug Delivery Systems” Polym Sci, 2017; 3(4):2471-9935.
39. Gómez-Guillén MC, Giménez B,Montero P, “Extraction of Gelatin From Fish Skins By High Pressure Treatment” IJPTP, 2017;7(1):1536-1548.
40. Devi A, Kamatchi P, LeelaK, “Extraction, Characterization and Application of Gelatin from Carcharhinus Amblyrhynchos and Sphyraena barracuda” JBB, 2016; 2(6):40-49.
41. Yadav P, Yadav H, Shah GV, Shah G, Dhaka G, “Biomedical Biopolymers, their Origin and Evolution in Biomedical Sciences: A Systematic Review” JCDR, 2015; 9(9):21-25.
42. Kulkarni VS, Butte KD, Rathod SS, “Natural Polymers – A Comprehensive Review” IJRPBS, 2012; 3(4):2229-3701.
43. Thomas BG, “Polymers and Biopolymers as Drug Delivery Systems in Nanomedicine” Recent Patents on Nanomedicine, 2012; 2:52-61.
44. Luca GJFM, Rui LR, “Natural polymers for the microencapsulation of cells” J R Soc Interface, 2014; 2(6):40-49.
45. Alam T, Parvez N, Kumar SP, “FDA-Approved Natural Polymers for Fast Dissolving Tablets” J Pharma, 2104; 3(4):1-6.
46. Azharuddin M, Danakka S, Krishnananda K, “Formulation and evaluation of fast disintegrating tablets of Granisetron HCl using natural polymers” Res Pharm, 2011; 1(2):20-27.
47. Scott AS, Patricia S. Wolfe, KG, Jennifer MM, Isaac A. Rodriguez L, Gary L. B, “The Use of Natural Polymers in Tissue Engineering: A Focus on Electrospun Extracellular Matrix Analogues” Polym, 2010; 2:522-553.
48. Islem Y, Marguerite R, “Chitin and Chitosan Preparation from Marine Sources. Structure.Properties and Applications” Mar Drugs, 2015; 13:1133-1174.
49. Babak G, Hadi A, “Biodegradable Polymers” InTech, 2013; 3(4):143-177.
50. Sahithi B, Ansari SK, Hameeda SK, “A Review on Collagen Based Drug Delivery Systems” IJRPB, 2013; 1(3):461-468.
51. Jagdale SC, Patil SA, Kuchekar BS, “Design, development and evaluation of floating tablets of tapentadol hydrochloride using chitosan” AJPCR, 2012; 5(4):163-168.
52. Ki-Won S, Yong-Seok K, Gap-Shik C, “Rheology of concentrated xanthan gum solutions: Steady shear flow behaviour” Fibers Polym, 2006; 7(2):129-138.
53. Sandolo C, Coviello T, Matricardi P,Alhaique F, “Characterization of polysaccharide hydrogels for modified drug delivery” Eur Biophys J, 2007; 36(7):693-700.
54. Santos H, Veiga F, Pina ME, Sousa JJ, “Compaction, compression and drug release properties of diclofenac sodium and ibuprofen pellets comprising xanthan gum as a sustained release agent” IJP, 2005; 295:15-27.
55. Sharma BR, Naresh L, Dhuldhoya NC, Merchant SU, Merchant UC, “Xanthan gum - A boon to food industry” Food Promotion Chronicle, 2006; 1(5):27-30.
56. Vishakha K, Kishor B, Sudha R, “Natural polymers – a comprehensive review” IJRPBS, 2012; 3(4):1597-1613.
57. Wang F, Wang YJ. Sun Z, “Conformational role of xanthan in its interaction with locust bean gum” JFS, 2002; 67(7):2609-2614.
58. Williams P, Clegg S, Day D, Phillips G. Nishinari K, “Mixed gels formed with konjacmannan and xanthan gum” In: Dickinson E, editor. Food polymers, gels and colloids, Cambridge, RSC, 1991; 339-348.
59. Xue D, Sethi R, “Viscoelastic gels of guar and xanthan gum mixtures provide long- term stabilization of iron micro and nanoparticles” J Nanoparticle Res, 2012; 14(11): 1-14.
60. Das D, Goyal A, “Charactrization and biocompatibility of glucan: a safe food additive from probiotic Lactobacillus plantarum DM5” J Sci Food Agric, 2014; 94(4):683-90.
61. Naessens M, Cerdobbel AN, Soetaert W, Vandamme EJ, “Leuconostoc dextran sucrase and dextran: production, properties and applications” JCTB, 2005; 80(8):845-60.
62. Patrushev VI, Shekhtman MA, “Role of blood coagulation in the pathogenesis of acute experimental pneumonias” Pathological physiology and general pathology, 1973; 75(5):508-510.
63. Giri SN, Benson J, Siegel DM, Rice SA, Schiedt M, “Effects of pretreatment with anti-inflammatory drugs on ozone-induced lung damage in rats” Proc Soc Exp Biol Med, 1975;150:810–14.
64. Awad HA, Butler DL, Boivin, G.P, “Autologous mesenchymal stem cell-mediated repair of tendon” Tissue Eng, 1999; 5(3):267-277.
65. Bruno FF, Akkara JA, Ayyagari M, Kaplan DL, Gross RS, Swift G, Dordiik JS, “EnxymaUc modifkatlon of Insoluble amylose in organic solvents”. Macromol, 1995; 28(7):8881-8883.
66. Bhavani AL, Nisha J, “Dextran—the polysaccharide with versatile uses” IJPBS, 2010; 1(4):569-73.
67. Sam E, LanceIon-Pin C, Ferigo F, Moreau V, Chanzy H, Driguez H, “Phosphorolytic synthesis of cellodextrins”. Carbohydr Res, 1995; 27(1):217-226.
68. Raymond S, Henriasat B, Gui DT, Kvick A, Chanxy H, “The crystal structure of methyl beta-cellotrloside monohydrate 0.25 ethanolate and its relatlonship to cellulose II” Carbohydr Res, 1995; 27(7):209-229.
69. Du SM, Wang H, Tse-Din Y-C, Seernan NC, “Topological transformations of synthetic DNA knots” Biochemistry, 1995; 34(2):673-682.
70. Du SM, Stellar BD, Swman NC, “A synthetic DNA molecule in three knotted topologies” J Am Chem Sot, 1995; 117(2):114-1200.
71. Kalousek S, Lubitz W, “High-level poly(β-hydroxybutyrate) production in recombinant Escherichia coli in sugar free, complex medium” Can J Microbial, 1995; 41(4):216-221.
72. Kang CK. Kusaka S, Doi Y, “Structure and properties of poly(3-hvdroxybutyrate-co-4-hydroxybutyrate) produced by Alcaligenes Iatus” Biotechnol Lett, 1995;1 7(8):583-588.
73. Archibald SJ, Krarup J, Shefner ST, Madison RD, “A collagen-based nerve guide conduit for peripheral nerve repair: an electrophysiological study of nerve regeneration in rodents and nonhuman primates” J Comp Neurol, 1991; 306(4):685-696.
74. Muller RH, Mader K, Gohla S, “Solid lipid nanoparticles for controlled drug delivery-A review of the state of the art” Eur J Pharm Biopharm, 2000; 50:161-177.
75. Jeyanthi R, Rao KP, “In vivo biocompatibility of collagen poly (hydroxyethyl methacrylate) hydrogels” Biomaterials, 1990; 1:238-243.
76. Woerly S, Maghami G, Duncan R, “Synthetic polymer derivatives as substrata for neuronal adhesion and growth” Brain Res Bull, 1993; 30:415-422.
77. Maeda M, Tani S, Sano A, Fujioka K, “Microstructure and release characteristics of the minipellet, a collagen based drug delivery system for controlled release of protein drugs” J Control Release, 1999; 62:313–24.
78. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ, “Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain” J Control Release, 1999; 59:299–307.
79. Koyama N, Dci Y, “Continuous production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) by Alcaligenes eutrophus” Biotechnol Lett, 1995; 17(6):281-204.
80. Dutta P K, Khatua M K, Dutta J, Prasad R, “Use of Chitosan-DMAc/LiCl gel as drug carriers” Int J Chem Sci, 2003; 1(2):93-102.
81. Dutta PK, DuttaJ, Tripathi VS, “Chitin and chitosan: Chemistry, properties and applications” JSIR, 2004; 63:20-31.
82. Becker DE, DDS, “Antithrombotic Drugs: Pharmacology and Implications for Dental Practice” Anesth Prog, 2013; 60(2):72-80.
83. Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, “Water-soluble and low molecular weight chitosan-based plasmid DNA delivery” Pharm Res, 2001; 18(4):427-431.
84. Lee D, Zhang W, Shirley SA, Kong X, Hellermann GR, “Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery” Pharm Res, 2007; 24(1):157-167.
85. Doi Y, “Microbial synthesis, physical properties, and biodegradabillty of polyhydroxyalkanoates” Macromol Symposia, 1995; 99(12):565-599.
86. Kato Y, Onishi H, Machida Y, “Application of chitin and chitosan derivatives in the pharmaceutical field” Curr Pharm Biotechnol, 2003; 4(5):303-309.
87. Rinaudo M, “Chitin and chitosan: Properties and applications” Prog Polym Sci, 2006; 31:603-632.
88. Atala A, Bauer S.B, Soker S, James J.Y, “Alan B. Retik.Tissue-engineered autologous bladders for patients needing cystoplasty” Lancet, 2006; 367(23):1241–1246.
89. Tungtong S, Okonogi S, Chowwanapoonpohn S, Phutdhawong W, Yotsawimonwat S, “Solubility, viscosity and rheological properties of water-soluble chitosan derivatives” MaejoInt J Sci Technol, 2012; 6(2):315-322.
90. Pillai CKS, Paul W, Sharma CP, “Chitin and chitosan polymers: Chemistry, solubility and fiber formation” Prog Polym Sci, 2009; 34:641-678.
91. Rodrigues A, Emeje M, “Recent applications of starch derivatives in nanodrug delivery” Carbohydr Polym, 2012; 87:987-994.
92. Quinlan GJ, Martin GS, Evans TW, “Albumin: Biochemical Properties and Therapeutic Potential”. Hepatology, 2005; 41(6):1211-1219.
93. Reddy N, Yang Y, “Potential of plant proteins for medical applications” Trends Biotechnol, 2011; 29(10):490-498.
94. Lai LF, Guo HX, “Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting” Int J of Pharm, 2011; 404(1-2):317-323.
95. Lee S, Alwahab NS, Moazzam ZM, “Zein-based oral drug delivery system targeting activated macrophages” Int J Pharm, 2013; 454(1):388-393.
96. Nagal A, Singla AK, “Applications of Silk in Drug Delivery: Advancement in Pharmaceutical Dosage Forms” Indo Global J Pharma Sci, 2013; 3(3):204-211.
97. Numata K, Kaplan DL, “Silk-based delivery systems of bioactive molecules” Adv Drug Deliv Rev.2010; 62(15):1497-1508.
98. Elzoghby AO, Samy WM, Elgindy NA, “Protein-based nanocarriers as promising drug and gene delivery systems” J Control Release, 2012; 161(1):38-49.
99. Shoulders MD, Raines RT, “Collagen Structure and stability” Annu Rev Biochem, 2009; 78:929-958.
100. Jha N, “Microbial Polysaccharides: Appication, Production and Features”. Available at: https://www.biologydiscussion.com/biotechnology/microbial-polysaccharides-application-production-and-features/10412
101. Iglesias N, Galbis E, Romero-Azogil L, Benito E, Lucas R, Gracia M, Violante de-Paz M, “In-Depth Study into Polymeric Materials in Low-Density Gastro-retentive Formulations” Pharmaceutics, 2020; 12:636-680.
102. Hadi MA, Rao NGR, Avanapu AR, Shiva G, Akram JW “Impact of capsules as a carrier for multiple unit drug delivery and the importance of HPMC capsules” RJPT, 2013; 6(1):34-43.
103. Singh D, Chaturvedi S, Agarwal V, Kumari P, “Approaches to increase the gastric residence time: Floating drug delivery systems- A review” AJPCR, 2010; 5:525-532.
104. Agarwal G, Agarwal S, Karar PK, Goyal S, “Oral Sustained Release Tablets: An Overview with a special emphasis on Matrix Tablet” Am J Adv Drug Deliv, 2017; 5:1–13.
105. Pawar VK, Kansal K, Garg G, Rajendra A, Singodia, Kulkarni G, “Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems” Drug Deliv, 2011; 18(2):97–110.
106. Rajpurohit H, Sharma P, Bhandari A, “Polymers for Colon Targeted Drug Delivery” IJPS, 2010; 72(6):689-696.
107. Elieh-Ali-Komi D, Hamblin R, “Chitin and Chitosan: Production and Application of Versatile Biomedical Nanoparticles” IJAR, 2016; 4(3):411–427.
Statistics
90 Views | 18 Downloads
How to Cite
1.
Das B, Paul S, Sharma H. A Review on Bio-Polymers Derived from Animal Sources with Special Reference to their Potential Applications. JDDT [Internet]. 15Mar.2021 [cited 20Apr.2021];11(2):209-23. Available from: http://jddtonline.info/index.php/jddt/article/view/4763